Melincoff Gwen A is a director of Protalix BioTherapeutics Inc.
Person profile
Roles
Protalix BioTherapeutics
Director
Gain Therapeutics
Director
Soleno Therapeutics
Director
Collegium Pharmaceutical
Director
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Protalix BioTherapeutics, Inc.
3 Oct 23
4
Gain Therapeutics, Inc.
26 Jun 23
4
SOLENO THERAPEUTICS INC
26 May 23
4
COLLEGIUM PHARMACEUTICAL, INC
19 May 23
4
SOLENO THERAPEUTICS INC
14 Oct 22
4
SOLENO THERAPEUTICS INC
14 Oct 22
4
Gain Therapeutics, Inc.
22 Sep 22
4
Protalix BioTherapeutics, Inc.
9 Sep 22
4
COLLEGIUM PHARMACEUTICAL, INC
23 May 22
4
SOLENO THERAPEUTICS INC
4 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Sep 23 | PLX Protalix BioTherapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 1.66 | 61,676 | 102.38 k | 61,676 |
23 Jun 23 | GANX Gain Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.5 | 10,500 | 47.25 k | 10,500 |
26 May 23 | SLNO Soleno Therapeutics | Stock option Common Stock | Grant | Acquire A | No | No | 5.25 | 10,000 | 52.50 k | 10,000 |
25 May 23 | SLNO Soleno Therapeutics | Stock option Common Stock | Grant | Acquire A | No | No | 5.03 | 2,666 | 13.41 k | 2,666 |
18 May 23 | COLL Collegium Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 9,792 | 0.00 | 44,775 |